JERUSALEM -- Sep 19, 2007 - Teva Pharmaceutical Industries announced today that the Company's synthetic peptide, edratide (TV-4710), did not meet its primary endpoint in the PRELUDE trial, a Phase 2 ...

Otezla is used to treat plaque psoriasis for whom phototherapy or systemic therapy is appropriate; active psoriatic arthritis; and oral ulcers associated with Behçet’s Disease. Glenmark has received ...

India's first private drug quality audit finds generics match branded medicines for safety and efficacy—at a fraction of the ...

The Generics Access Project and 46 patient advocacy organizations sent a letter on May 21 to the Senate HELP and House Energy & Commerce leadership to stress the urgent need for congressional action ...